Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Debt to Equity (2019 - 2020)

aTYR PHARMA's Debt to Equity history spans 2 years, with the latest figure at $0.1 for Q3 2020.

  • For Q3 2020, Debt to Equity fell 75.84% year-over-year to $0.1; the TTM value through Sep 2020 reached $0.1, down 75.84%, while the annual FY2019 figure was $0.42, N/A changed from the prior year.
  • Debt to Equity reached $0.1 in Q3 2020 per ATYR's latest filing, down from $0.14 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.48 in Q1 2019 to a low of $0.1 in Q3 2020.